DE60008497D1 - Arzneimittel zur oralen verabreichung - Google Patents

Arzneimittel zur oralen verabreichung

Info

Publication number
DE60008497D1
DE60008497D1 DE60008497T DE60008497T DE60008497D1 DE 60008497 D1 DE60008497 D1 DE 60008497D1 DE 60008497 T DE60008497 T DE 60008497T DE 60008497 T DE60008497 T DE 60008497T DE 60008497 D1 DE60008497 D1 DE 60008497D1
Authority
DE
Germany
Prior art keywords
oral administration
medicinal products
dissolving
granular formulations
administration medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60008497T
Other languages
English (en)
Other versions
DE60008497T2 (de
Inventor
Masaaki Nomura
Takumi Kojima
Shigenori Nozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Publication of DE60008497D1 publication Critical patent/DE60008497D1/de
Application granted granted Critical
Publication of DE60008497T2 publication Critical patent/DE60008497T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
DE60008497T 1999-10-12 2000-10-11 Arzneimittel zur oralen verabreichung Expired - Fee Related DE60008497T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29034199 1999-10-12
JP29034199 1999-10-12
PCT/JP2000/007045 WO2001026691A1 (fr) 1999-10-12 2000-10-11 Compositions medicamenteuses pour administration orale

Publications (2)

Publication Number Publication Date
DE60008497D1 true DE60008497D1 (de) 2004-04-01
DE60008497T2 DE60008497T2 (de) 2004-12-02

Family

ID=17754808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008497T Expired - Fee Related DE60008497T2 (de) 1999-10-12 2000-10-11 Arzneimittel zur oralen verabreichung

Country Status (11)

Country Link
EP (1) EP1138333B1 (de)
JP (1) JP4731777B2 (de)
KR (1) KR20010089886A (de)
CN (1) CN1171639C (de)
AT (1) ATE260120T1 (de)
CA (1) CA2354558A1 (de)
DE (1) DE60008497T2 (de)
DK (1) DK1138333T3 (de)
ES (1) ES2215731T3 (de)
PT (1) PT1138333E (de)
WO (1) WO2001026691A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1411986B1 (de) * 2001-07-30 2008-03-12 DSM IP Assets B.V. Zusammensetzung enthaltend epigallocatechin-gallat
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
CN100337628C (zh) * 2002-08-07 2007-09-19 王登之 治疗痴呆症的尼莫地平口腔崩解片及其制备方法
JP4640821B2 (ja) * 2003-07-24 2011-03-02 塩野義製薬株式会社 難水溶性薬物を含むドライシロップ剤
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
CA2560613C (en) 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
FR2882655B1 (fr) * 2005-03-07 2007-04-27 Vetoquinol Sa Sa Nouveau procede d'obtention d'une poudre d'imidapril a dissolution rapide
CN100398546C (zh) * 2005-06-29 2008-07-02 上海医药科技发展有限公司 碳青霉烯类抗生素法罗培南钠的制备方法
WO2007014896A1 (en) 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
JP5202856B2 (ja) * 2006-03-06 2013-06-05 富山化学工業株式会社 トシル酸トスフロキサシンを含有する粒状固形製剤
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
JP2010013357A (ja) * 2008-07-01 2010-01-21 Takada Seiyaku Kk 高含量ｌ−カルボシステインドライシロップ剤
CN101513409B (zh) * 2009-03-24 2011-03-09 深圳立健药业有限公司 一种头孢氨苄的药物组合物
CN101744782B (zh) * 2010-01-24 2012-03-21 鲁南贝特制药有限公司 一种含有法罗培南钠的片剂
KR101038260B1 (ko) * 2010-11-24 2011-05-31 전찬호 튜브용접 보조 기구
WO2013093939A2 (en) * 2011-10-31 2013-06-27 Emcure Pharmaceuticals Limited Compositions of aliphatic amine polymers
CN113521116A (zh) * 2021-08-18 2021-10-22 东莞市东阳光冬虫夏草研发有限公司 一种冬虫夏草组合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867523A (en) * 1970-06-08 1975-02-18 American Home Prod Stabilization of ampicillin with sucrose
JPS5418330B2 (de) * 1973-03-16 1979-07-06
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
LU77362A1 (de) * 1977-05-17 1979-01-19
US4540689A (en) * 1981-09-22 1985-09-10 Kureha Kagaku Kogyo Kabushiki Kaisha Penicillin derivative
GB2124614B (en) * 1982-07-01 1985-10-30 Erba Farmitalia Easily cleavable carboxylic esters and their use in the synthesis of penems and other b-lactam antibiotics
JPS59175414A (ja) * 1983-03-23 1984-10-04 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
FI853005L (fi) * 1984-08-09 1986-02-10 Ciba Geigy Ag Nya aminoalkylpenem-foereningar.
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
US4826832A (en) * 1986-05-06 1989-05-02 Ciba-Geigy Corporation Penen compounds
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
JPH0813750B2 (ja) * 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物
JP2609022B2 (ja) * 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
JPH06157312A (ja) * 1992-11-12 1994-06-03 Shionogi & Co Ltd 苦味改善テルフェナジンドライシロップ顆粒剤
JP2916984B2 (ja) * 1993-12-27 1999-07-05 エスエス製薬株式会社 粒状製剤の製造法
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
WO1998003202A1 (fr) * 1996-07-23 1998-01-29 Daiichi Pharmaceutical Co., Ltd. Agents absorptifs
JPH1045619A (ja) * 1996-07-31 1998-02-17 Kaken Pharmaceut Co Ltd 成長ホルモン分泌促進ペプチド含有経口製剤
JPH1171285A (ja) * 1997-06-30 1999-03-16 Chugai Pharmaceut Co Ltd スクラルファート含有組成物及びその製造方法
KR20000076105A (ko) * 1998-01-13 2000-12-26 도리이 신이찌로 항생제를 함유한 국소 투여용 항균 조성물
JP2000086520A (ja) * 1998-09-08 2000-03-28 Takada Seiyaku Kk メキタジン製剤

Also Published As

Publication number Publication date
DK1138333T3 (da) 2004-05-24
JP4731777B2 (ja) 2011-07-27
DE60008497T2 (de) 2004-12-02
CN1336827A (zh) 2002-02-20
KR20010089886A (ko) 2001-10-12
EP1138333B1 (de) 2004-02-25
CN1171639C (zh) 2004-10-20
EP1138333A4 (de) 2002-01-02
EP1138333A1 (de) 2001-10-04
WO2001026691A1 (fr) 2001-04-19
ES2215731T3 (es) 2004-10-16
CA2354558A1 (en) 2001-04-19
PT1138333E (pt) 2004-07-30
ATE260120T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
DE60008497D1 (de) Arzneimittel zur oralen verabreichung
EE05074B1 (et) Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
MY128809A (en) Pharmaceutical formulation of omeprazole
ATE277594T1 (de) Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
DE69432559D1 (de) Verwendung von eisenbindenden polymeren zur herstellung eines medikaments zur oralen verabreichung
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
EE05196B1 (et) Heteroarlsulfonlklgahelaga antraniilamiidid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad ravimpreparaadid
DE69815094D1 (de) 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DE60301570D1 (de) 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE294175T1 (de) 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE60010113D1 (de) N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
HU0203718D0 (en) Oral veterinary drug delivery system and/or feed additive delivery system, process for the preparation and use thereof
DE60032372D1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
DE60003662D1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE50000864D1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
AU2907800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
NO883986D0 (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
DE3878154D1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
NO971574L (no) Medisinmateanordning for tildeling av medisin via munnen, beregnet for spedbarn og mindre barn
NZ243552A (en) 2-[2-(4-methoxy-2-pyridinyl)phenylsulphinyl]-1h-benzimidazole derivatives, preparation and pharmaceutical compositions thereof
ATE141593T1 (de) Leukotrien-b 4?-derivative, verfahren zu ihrer herstellung und arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee